180 related articles for article (PubMed ID: 24451147)
1. Atorvastatin prevents ATP-driven invasiveness via P2X7 and EHBP1 signaling in PTEN-expressing prostate cancer cells.
Ghalali A; Wiklund F; Zheng H; Stenius U; Högberg J
Carcinogenesis; 2014 Jul; 35(7):1547-55. PubMed ID: 24451147
[TBL] [Abstract][Full Text] [Related]
2. Statins and ATP regulate nuclear pAkt via the P2X7 purinergic receptor in epithelial cells.
Mistafa O; Högberg J; Stenius U
Biochem Biophys Res Commun; 2008 Jan; 365(1):131-6. PubMed ID: 17980145
[TBL] [Abstract][Full Text] [Related]
3. Statins exhibit anticancer effects through modifications of the pAkt signaling pathway.
Miraglia E; Högberg J; Stenius U
Int J Oncol; 2012 Mar; 40(3):867-75. PubMed ID: 21994073
[TBL] [Abstract][Full Text] [Related]
4. Purinergic receptor-mediated rapid depletion of nuclear phosphorylated Akt depends on pleckstrin homology domain leucine-rich repeat phosphatase, calcineurin, protein phosphatase 2A, and PTEN phosphatases.
Mistafa O; Ghalali A; Kadekar S; Högberg J; Stenius U
J Biol Chem; 2010 Sep; 285(36):27900-10. PubMed ID: 20605778
[TBL] [Abstract][Full Text] [Related]
5. Statins inhibit Akt/PKB signaling via P2X7 receptor in pancreatic cancer cells.
Mistafa O; Stenius U
Biochem Pharmacol; 2009 Nov; 78(9):1115-26. PubMed ID: 19540829
[TBL] [Abstract][Full Text] [Related]
6. Silencing p110β prevents rapid depletion of nuclear pAkt.
Ye ZW; Ghalali A; Högberg J; Stenius U
Biochem Biophys Res Commun; 2011 Dec; 415(4):613-8. PubMed ID: 22074824
[TBL] [Abstract][Full Text] [Related]
7. P2X7 mediates ATP-driven invasiveness in prostate cancer cells.
Qiu Y; Li WH; Zhang HQ; Liu Y; Tian XX; Fang WG
PLoS One; 2014; 9(12):e114371. PubMed ID: 25486274
[TBL] [Abstract][Full Text] [Related]
8. Cytosolic phospholipase A2α sustains pAKT, pERK and AR levels in PTEN-null/mutated prostate cancer cells.
Hua S; Yao M; Vignarajan S; Witting P; Hejazi L; Gong Z; Teng Y; Niknami M; Assinder S; Richardson D; Dong Q
Biochim Biophys Acta; 2013 Jun; 1831(6):1146-57. PubMed ID: 23500889
[TBL] [Abstract][Full Text] [Related]
9. Atorvastatin Decreases HBx-Induced Phospho-Akt in Hepatocytes via P2X Receptors.
Ghalali A; Martin-Renedo J; Högberg J; Stenius U
Mol Cancer Res; 2017 Jun; 15(6):714-722. PubMed ID: 28209758
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of atorvastatin on the cell growth of cardiac myxomas via the PTEN and PHLPP2 phosphatase signaling pathway.
Wu XL; Yang DY; Tan DJ; Yao HC; Chai W; Peng L
Oncol Rep; 2013 Aug; 30(2):757-62. PubMed ID: 23715723
[TBL] [Abstract][Full Text] [Related]
11. Pleiotropic role of atorvastatin in regulation of human retinal pigment epithelial cell behaviors in vitro.
Wu WC; Lai YH; Hsieh MC; Chang YC; Wu MH; Wu HJ; Chang CW; Wu KY; Kao YH
Exp Eye Res; 2011 Dec; 93(6):842-51. PubMed ID: 21989109
[TBL] [Abstract][Full Text] [Related]
12. P2X7 receptor stimulates breast cancer cell invasion and migration via the AKT pathway.
Xia J; Yu X; Tang L; Li G; He T
Oncol Rep; 2015 Jul; 34(1):103-10. PubMed ID: 25976617
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin inhibits GSK-3beta phosphorylation by cardiac hypertrophic stimuli.
Planavila A; Rodríguez-Calvo R; Palomer X; Coll T; Sánchez RM; Merlos M; Laguna JC; Vázquez-Carrera M
Biochim Biophys Acta; 2008; 1781(1-2):26-35. PubMed ID: 18036354
[TBL] [Abstract][Full Text] [Related]
14. Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion.
Shukla S; Maclennan GT; Hartman DJ; Fu P; Resnick MI; Gupta S
Int J Cancer; 2007 Oct; 121(7):1424-32. PubMed ID: 17551921
[TBL] [Abstract][Full Text] [Related]
15. Atorvastatin inhibited Rho-associated kinase 1 (ROCK1) and focal adhesion kinase (FAK) mediated adhesion and differentiation of CD133+CD44+ prostate cancer stem cells.
Rentala S; Chintala R; Guda M; Chintala M; Komarraju AL; Mangamoori LN
Biochem Biophys Res Commun; 2013 Nov; 441(3):586-92. PubMed ID: 24177008
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of the inhibitory effect of atorvastatin on endoglin expression induced by transforming growth factor-beta1 in cultured cardiac fibroblasts.
Shyu KG; Wang BW; Chen WJ; Kuan P; Hung CR
Eur J Heart Fail; 2010 Mar; 12(3):219-26. PubMed ID: 20156938
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of Phospholipase Cε (PLCε) Inhibits Cell Proliferation via Phosphatase and Tensin Homolog Deleted on Chromosome 10 (PTEN)/AKT Signaling Pathway in Human Prostate Cancer.
Wang X; Fan Y; Du Z; Fan J; Hao Y; Wang J; Wu X; Luo C
Med Sci Monit; 2018 Jan; 24():254-263. PubMed ID: 29330357
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of serotonin-induced mitogenesis, migration, and ERK MAPK nuclear translocation in vascular smooth muscle cells by atorvastatin.
Li M; Liu Y; Dutt P; Fanburg BL; Toksoz D
Am J Physiol Lung Cell Mol Physiol; 2007 Aug; 293(2):L463-71. PubMed ID: 17545489
[TBL] [Abstract][Full Text] [Related]
19. CXCR4 and PTEN are involved in the anti-metastatic regulation of anethole in DU145 prostate cancer cells.
Rhee YH; Chung PS; Kim SH; Ahn JC
Biochem Biophys Res Commun; 2014 May; 447(4):557-62. PubMed ID: 24525130
[TBL] [Abstract][Full Text] [Related]
20. Statins induce mammalian target of rapamycin (mTOR)-mediated inhibition of Akt signaling and sensitize p53-deficient cells to cytostatic drugs.
Roudier E; Mistafa O; Stenius U
Mol Cancer Ther; 2006 Nov; 5(11):2706-15. PubMed ID: 17121917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
